1. Sheagren JN, Schaberg DR. Staphylococci In: Gorbach SL, Barlett JG, Blacklow NR (eds) Infect i ous D i seases. 2nd ed. Ph iladelph i a. W.B. Saunders Company 1998; 1697-703.
2. Howard BJ, Kloos WE. Staphylococci. In: Howard BJ, Klaas II J, Rub in SJ, We i ssfeld AS, Ti lton RC (eds). Cl in i cal and Pathogen i c M i crob i ology. St Lou is. CV Mosby 1987; 231-44.
3.
Çet
i nkaya Y, Ünal S. Stafi lokokal Nazal Taşıyıcılık. Önem i ve Tedavi si. Hast İnfeksiyon Derg is i. 1999; 3: 22-3.
4. Asensi o A, Guerrero A, Quereda C et al. Colon izati on and i nfecti on with meth ici ll i n-resistant Staphylococcus aureus : associated factors and erad i cati on. Infect Control Hosp Ep idem i ol 1996; 17: 20-8.
5. Boyce JM, Landrey M, Deetz TR, Dupont HL. Ep idemiolog i c stud ies of an autbreak of nosocom al meth c ll n-res stant Staphylococcus aureus i nfect i ons. Infect Control 1981; 2: 1110-6.
6. Lebleb
i
c
i oğlu H. Hastane ep i dem i leri: Meti si l in D i rençl i Stafi lokoklar. Aktüel Tıp Derg is i 1996; 1: 457-60.
7. Duckworth G, Cookson C, Hamphreys H, Heathcock R. Revised gu i del i nes for the control of meth i c ill i n resi stant Staphylococcus aureus i nfect i on i n hosp itals. J Hosp Infect 1998; 39: 253-90.
8. Kluytmans J, Belkum A, Verbrugh H. Nasal carri age of Staphylococcus aureus ep idem i ology, underlyi ng mechan isms and associ ated ri sks. Cl i n M i crob i ol Rev 1997; 3: 505-20.
9. Boyce JM. Meth c ll n-res stant Staphylococcus aureus (MRSA) : cost benefit impl i cat i ons of preventi ng the spread of MRSA i nfecti on duri ng an outbreak. Internati onal Cl i n i cal Practi ce Seri es. The cost and Cl i n i cal Impact of Staphylococcal infect i on: Strateg i es to ach i eve preventi on. 1995; 17-27.
10. Koneman EW, Allen SD, Janda WM et al. Color Atlas and Textbook of D i agnosti c M i crob i ology. 5th ed. Ph i ladelph ia 1997: 541-4.
11. Nat i onal Comm itte for Cl in i cal Laboratory Standarts. Performans standarts for antimicrobial susceptibility testing. NCCLS document sixth approved standard M2-A6, Vol 17 Jan 1997.
12.
Kalel
i İ, Özen N, Yalçın AN, Akşit F. Hastane personelinde burunda Staphylococcus aureus taşıyıcılığının saptanması. İnfeksiyon Dergisi. 1997; 11(3): 243-5.
13.
Ba
l Ç, Aydın MD, Anğ Ö. Tıp personelinde stafilokok kolonizasyonu. İnfeksiyon Dergisi. 1997; 11(3) : 237-42.
14. Bouza E, Perez-Molina J, Munoz P. On behalf of the Cooperative Group
of the European Study Group on Nosocomial Infections (ESGNI). Report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin Microbiol Infect 1999; 5: 1-12.
15. Rubin RJ, Harrington AC, Poon A et al. The economic impact of S. aureus infection in New York City Hospitals. Emerg Infect Dis 1999;5:9-
17.
16. Alonso-Echanove J, Robles B, Jarvis WR et al. Proficiency of Clinical Laboratories in Spain in Detecting Vancomycin-Resistant Enterococcus spp. J Clin Microbiol 1999; 37: 2148-52.
17. Rotun SS, McMath V, Schoonmaker DJ et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis. 1999; 5: 147-9.
18.
Dile
r M, Altanlar N, Emekdaş G ve ark. Hastane ortam ve cihazlarından izole edilen Stafilokok suşlarında oksasilin, fusidik asit, mupirocin ve değişik diğer antibiyotiklere direnç. ANKEM Derg 1999; 13: 53-6.
Thank you for copying data from http://www.arastirmax.com